BLBD Form 4: Horlock Exercises Options and Sells 13,000 Shares
Rhea-AI Filing Summary
Phil Horlock, a director of Blue Bird Corporation (BLBD), reported transactions on 08/28/2025. The filing shows acquisition of 13,000 shares via a stock option exercise transaction coded M at an exercise price of $20.26 and a contemporaneous disposition of 13,000 shares sold at $59.02, reducing his directly held common stock from 253,766 to 240,766 shares. Table II reports a stock option with exercise price $20.26 covering 13,000 underlying shares exercisable as of 10/31/2021 and expiring 12/31/2026, leaving 13,578 shares of derivative securities beneficially owned after the transactions. The form is signed by an attorney-in-fact on 09/02/2025.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine insider option exercise and share sale by a director; net direct holdings decreased by 13,000 shares.
The filing documents a paired transaction: an option-related acquisition at an exercise price of $20.26 and a sale of the same number of shares at $59.02, indicating cashing out of shares associated with prior grants. The director remains a significant holder with 240,766 direct shares and 13,578 derivative shares after the reported activity. This appears to be an ordinary Section 16 disclosure of insider activity rather than a corporate-change event.
TL;DR: Disclosure shows accelerated vesting history and routine reporting; no governance action or departure is reported here.
The explanatory note clarifies that option vesting dates were accelerated earlier upon the director's initial retirement, which explains the exercisable date and the current option holdings. The form identifies Mr. Horlock as a director and is filed as a single reporting person submission. The signature via attorney-in-fact is properly noted; the filing does not disclose changes to board composition or executive roles.